Prescryptive and Ilant Health have announced a partnership aimed at giving employers direct access to GLP-1 therapies with transparent pricing and expert clinical care. This collaboration leverages Prescryptive’s direct-to-market platform to provide affordable, flexible prescription access, while Ilant Health’s Center of Excellence delivers personalized obesity care. Through this model, employers can offer structured obesity management programs that include high-value prescribing, lifestyle support, and outcome tracking, ensuring predictable costs and measurable results.
Health Technology Insights: OrthAlign Expands Lantern Hip Platform for Posterior THA
Chris Blackley, CEO and Co-Founder of Prescryptive, emphasized that simply offering pricing transparency is not enough for employer-directed GLP-1 programs. He explained that successful programs must combine clinical oversight, economic predictability, and accountable access. According to Blackley, the partnership brings these elements together, with Ilant Health providing the clinical expertise, manufacturers offering direct pricing, and Prescryptive connecting employers to the program.
Ilant Health’s Center of Excellence approach combines evidence-based obesity care, nationwide clinical coverage, and configurable employer benefit design to deliver measurable health outcomes. Elina Onitskansky, CEO and Co-Founder of Ilant Health, said their model allows them to provide rigorous, personalized obesity and cardiometabolic care while offering employers flexibility in program design. She added that Prescryptive’s platform supports customized GLP-1 access and cost transparency, helping employers manage high-value treatments responsibly.
Health Technology Insights: Solventum Wins Diamond HIRC Badge for Top Supply Chain Strength
Employers using Ilant’s programs have seen strong results, including over 90 percent of participants remaining on therapy at six months, an average weight loss of 15 percent across multiple treatment options, and an increase in preventive care engagement among members who had not seen a physician in the past year.
Prescryptive’s platform is built specifically to support employer-directed GLP-1 programs managed through Centers of Excellence. It integrates a national pharmacy network, direct-access pricing, and claims execution, enabling employers to implement consistent, clinically governed programs. The platform also provides eligibility verification, program rule enforcement, and outcome reporting to ensure real-world performance aligns with expectations.
Rae McMahan, Senior Vice President of Payer Solutions at Prescryptive, noted that employer demand for clinically rigorous and financially sustainable GLP-1 access continues to grow. She explained that the platform creates a closed-loop ecosystem where manufacturers, Centers of Excellence, and employers can work together, aligning incentives while ensuring affordability, transparency, and scalable access. This collaboration represents a new model for delivering high-value obesity care with measurable outcomes and accountable stewardship.
Health Technology Insights: Ferronova Raises $6 Million to Boost Image-Guided Cancer Surgery
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
